Vukadinović, Davor
Abdin, Amr
Emrich, Insa
Schulze, P. Christian
von Haehling, Stephan
Böhm, Michael
Funding for this research was provided by:
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
Article History
Received: 19 February 2023
Accepted: 24 March 2023
First Online: 19 April 2023
Declarations
:
: D.V. and A.A. have no conflict of interest to declare; I.E.E. received advisory board and speaker honoraria from Pharmacosmos and Astellas. C.S. received honoraria and travel support from Bayer, Astra Zeneca, Daiichi Sankyo, Novartis, Actelion, Roche, Sanofi Aventis, Pharmacosmos, Medtronic, Thoratec, Boehringer Ingelheim, HeartWare, Coronus, Abbott, Edwards Inc, Boston Scientific, St Jude Medical, Abiomed, and the German Cardiac Society; research support from the National Institutes of Health, the German Research Foundation, the Else Kröner Fresenius Foundation, the German Heart Foundation, the European Society of Cardiology, Actelion, Medtronic, BMBF, Abiomed, Boehringer Ingelheim, and Boston Scientific; and served on advisory boards for the German Research Council, Eurotransplant, Novartis, Bayer, Pharmacosmos, Astra Zeneca, Boehringer Ingelheim Inc, the German Cardiac Society, and the European Society of Cardiology; S.v.H. has been a paid consultant for and/or received honoraria payments from AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, Chugai, Grünenthal, Helsinn, Hexal, Novartis, Pharmacosmos, Respicardia, Roche, Servier, Sorin, and Vifor. S.v.H. reports research support from Amgen, Boehringer Ingelheim, IMI, and the German Center for Cardiovascular Research (DZHK); M.B. is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219, project number 322900939) and reports personal fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards, Medtronic, Novartis, Recor, Servier and Vifor.